You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-VEGF (VEGFA) Antibodies

Full name:
anti-Vascular Endothelial Growth Factor A Antibodies (VEGFA)
On www.antibodies-online.com are 361 Vascular Endothelial Growth Factor A (VEGFA) Antibodies from 34 different suppliers available. Additionally we are shipping VEGF Proteins (130) and VEGF Kits (115) and many more products for this protein. A total of 624 VEGF products are currently listed.
Synonyms:
eVEGF120, eVEGF164, MVCD1, vefg, Vegf, VEGF-A, Vegf120, VEGF164, Vegf188, vegfa, Vpf, wu:fj82c06
list all antibodies Gene Name GeneID UniProt
VEGFA 7422 P15692
VEGFA 22339 Q00731
VEGFA 83785 P16612

Show all species

Show all synonyms

All available anti-VEGF Antibodies

Go to our pre-filtered search.

Top referenced anti-VEGF Antibodies

  1. Human Polyclonal VEGF Primary Antibody for EIA, WB - ABIN955508 : Shrivastava-Ranjan, Rollin, Spiropoulou: Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin. in Journal of virology 2010 (PubMed)
    Show all 5 references for ABIN955508

  2. Guinea Pig Polyclonal VEGF Primary Antibody for IF (p), IHC (p) - ABIN707186 : Wang, Liao, Wang, Deng, Yu: Transplantation of bone marrow stromal cells overexpressing human vascular endothelial growth factor 165 enhances tissue repair in a rat model of radiation-induced injury. in Chinese medical journal 2014 (PubMed)
    Show all 3 references for ABIN707186

  3. Human Polyclonal VEGF Primary Antibody for EIA, IHC (p) - ABIN155190 : Breier, Albrecht, Sterrer, Risau: Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. in Development (Cambridge, England) 1992 (PubMed)
    Show all 3 references for ABIN155190

  4. Human Monoclonal VEGF Primary Antibody for EIA, Func - ABIN155173 : Kim, Li, Houck, Winer, Ferrara: The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. in Growth factors (Chur, Switzerland) 1992 (PubMed)
    Show all 2 references for ABIN155173

  5. Human Monoclonal VEGF Primary Antibody for FACS - ABIN4898939 : Lee, Myers, Kim: Vascular endothelial growth factor drives autocrine epithelial cell proliferation and survival in chronic rhinosinusitis with nasal polyposis. in American journal of respiratory and critical care medicine 2009 (PubMed)

  6. Human Polyclonal VEGF Primary Antibody for IF (p), IHC (p) - ABIN675893 : Ryzhov, Goldstein, Novitskiy, Blackburn, Biaggioni, Feoktistov: Role of A2B adenosine receptors in regulation of paracrine functions of stem cell antigen 1-positive cardiac stromal cells. in The Journal of pharmacology and experimental therapeutics 2012 (PubMed)

  7. Human Monoclonal VEGF Primary Antibody for Func - ABIN180646 : Brown, Berse, Jackman, Tognazzi, Guidi, Dvorak, Senger, Connolly, Schnitt: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. in Human pathology 1995 (PubMed)

  8. Human Monoclonal VEGF Primary Antibody for IHC (p) - ABIN114925 : Turley, Scott, Watts, Bicknell, Harris, Gatter: Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1. in The Journal of pathology 1999 (PubMed)

More Antibodies against VEGF Interaction Partners

Zebrafish Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. Tmem2 regulates hyaluronic acid turnover to promote normal Vegf signaling during developmental angiogenesis.

  2. low levels of Vegf signaling promote overall vascular endothelial differentiation and cell survival by upregulating etv2 expression, while high levels of Vegf signaling promote arterial and inhibit venous specification.

  3. altering the amount of VEGF signaling in endothelial cells by stimulating them with different VEGF concentrations triggered distinct and mutually exclusive dynamic Ca(2 (show CA2 Antibodies)+) signaling responses that correlated with different cellular behaviors.

  4. Bis(2,3-dibromo-4,5-dihydroxybenzyl) ether downregulate the expression of VEGF and VEGFR, and simultaneously regulates VEGF signaling pathway to prevent angiogenesis.

  5. noncanonical function of tars (show TARS Antibodies) regulates vascular development presumably by modulating the expression of vegfa

  6. Methylglyoxal acts on smaller blood vessels in zebrafish via the VEGF receptor (show FLT1 Antibodies) signaling cascade, thereby describing a new mechanism that can explain vascular complications under hyperglycemia and elevated MG concentrations.

  7. The translation initiation factor eIF3i (show EIF3I Antibodies) up-regulates VEGF-A, accelerates cell proliferation, and promotes angiogenesis in embryonic development.

  8. lack of SULF1 (show SULF1 Antibodies) expression downregulates VEGFA-mediated arterial marker expression, confirming that Sulf1 (show SULF1 Antibodies) mediates arterial specification by regulating VegfA165 activity.

  9. yolk-derived 17beta-estradiol sets the ventral boundary of hemogenic vascular niche specification by antagonizing the dorsal-ventral regulatory limits of VEGF.

  10. Vegfaa has a crucial role in angiogenesis and vegfaa expression was upregulated in embryos lacking functional Pten (show PTEN Antibodies).

Xenopus laevis Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. VEGFA produced in the somites is required to initiate adult haemangioblast programming in the adjacent dorsal lateral plate mesoderm.

  2. sequential, isoform-specific VEGFA signaling successively induces the endothelial, arterial, and hematopoietic stem cell programs in the dorsal aorta.

  3. VEGF induces stromal cell migration or recruitment that are required for blood vessel formation.

  4. increased VEGF(170) levels disturb Hand-1 (show HAND1 Antibodies) expression in the region required for normal heart morphogenesis

Cow (Bovine) Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. data for the first time demonstrate a calpain/PTP1B/VEGFR2 negative feedback loop in the regulation of VEGF-induced angiogenesis. Modulation of local PTP1B and/or calpain activities may prove beneficial in the treatment of impaired wound healing in diabetes.

  2. Studied the effect of cyclic uniaxial stretch (20%, 1 Hz), with and without the stimulation of vascular endothelial growth factor (VEGF), on sprouting angiogenesis by employing a stretchable three-dimensional cell culture model.

  3. Study shows that VEGFA mRNA in mammalian endothelial cells undergoes programmed translational readthrough (PTR) generating VEGF-Ax, an isoform containing a unique 22-amino-acid C terminus extension.

  4. Data indicate that superoxide dismutase (SOD) inhibited high glucose (HG)-induced expression of uPAR and VEGF in bovine retinal microvascular endothelial cell (REC).

  5. Exposure of endothelial cells to VEGF, high glucose, or hydrogen peroxide up-regulated the XBP1 (show XBP1 Antibodies)/IRE1 alpha (show ERN1 Antibodies) and ATF6 (show ATF6 Antibodies) arms of the unfolded protein response compared with untreated cells.

  6. Microvascular endothelial cells are more susceptible than aortic cells to advanced glycation end products-enhanced permeability and that AGE-enhanced permeability is dependent on VEGF expression induced by reactive oxygen species.

  7. VEGF supports germ cell survival and sperm production in bulls.

  8. analysis of polymorphisms of bovine VEGF gene and their associations with growth traits in Chinese cattle

  9. VEGF mRNA expression at estrus was higher than at the early I, early II and late luteal stages (P<0.05), whereas VEGF protein content was greatest at the early I luteal stage and decreased thereafter

  10. Alterations in the expression of VEGF-A and bFGF (show FGF2 Antibodies) systems suggest that angiogenic factors are involved in abnormal placental development in cloned gestations, contributing to impaired fetal development and poor survival rates.

Human Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. Combined cytotoxic therapy and targeted anti-VEGF therapy for colorectal adenocarcinoma metastases to the liver leads to some suppression of the alternative pathway in the formation of new vessels, by reducing the expression of CXCR4 in the vessel endothelial cells and that of VEGF in the stromal cells from the metastatic foci

  2. This study confirms the contribution of altered VEGF secretion, resulting from genetic variation in VEGFA gene into the pathogenesis of pathogenesis of polycystic ovary syndrome.

  3. HuR (show ELAVL1 Antibodies) plays important roles in determining malignant aggressiveness and outcome in prostate cancer (PCa (show FLVCR1 Antibodies)), especially in androgen-independent PCa (show FLVCR1 Antibodies) cells, via the regulation of cell proliferation, migration, and expression of VEGF-A, -C, and COX-2 (show COX2 Antibodies).

  4. direct-acting antivirals administration induces an early increase in serum VEGF and a change in the inflammatory pattern, coinciding with HCV clearance. This may alter the balance between inflammatory and anti-inflammatory processes and modify the antitumor surveillance of the host.

  5. this study shows that 1,25(OH)2D3 can alleviate house dust mite-induced airway epithelial barrier dysfunction by inhibiting PI3K pathway-dependent VEGF release

  6. MicroRNA-29b inhibits angiogenesis by targeting VEGFA through the MAPK/ERK (show MAPK1 Antibodies) and PI3K (show PIK3CA Antibodies)/Akt (show AKT1 Antibodies) signaling pathways in endometrial carcinoma.

  7. Our results show a miRNA editing activity trend aligning with cellular pathways closely associated to hypoxia, such as the VEGF and PI3K (show PIK3CA Antibodies)/Akt (show AKT1 Antibodies) pathways, providing important novel insights on this poorly elucidated phenomenon.

  8. Patients with post-peripartum cardiomyopathy have significantly higher plasma sFlt1 (show FLT1 Antibodies) concentration with a trend of somewhat higher levels of VEGF and significantly decreased VEGF/sFlt1 (show FLT1 Antibodies) ratio compared to controls.

  9. ANRIL regulates VEGF expression and function in diabetic retinopathy. This regulation is mediated by p300 (show EP300 Antibodies), miR200b, and EZH2 (show EZH2 Antibodies) of the PRC2 complex.

  10. autocrine VEGF and IL-8 (show IL8 Antibodies) promoted endothelial cell migration via the Src (show SRC Antibodies)/Vav2 (show VAV2 Antibodies)/Rac1/PAK1 (show PAK1 Antibodies) signaling pathway.

Mouse (Murine) Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. MicroRNA-29b inhibits angiogenesis by targeting VEGFA through the MAPK/ERK (show MAPK1 Antibodies) and PI3K/Akt (show AKT1 Antibodies) signaling pathways in endometrial carcinoma.

  2. Data show that receptor for activated C-kinase 1 (RACK1) and vascular endothelial growth factor (VEGF) expression is up-regulated after choroidal neovascularization (CNV) formation.

  3. beta2-AR activation also stimulated VEGF and IL-6 (show IL6 Antibodies) mRNA expression by 2- and 10-fold, respectively.

  4. XBP1 regulates VEGF-mediated cardiac angiogenesis.

  5. First-in-class selective PET tracers for imaging VEGFR-1 (show FLT1 Antibodies) and VEGFR-2 (show KDR Antibodies) were constructed and successfully validated in an orthotopic murine tumor model.

  6. data for the first time demonstrate a calpain/PTP1B/VEGFR2 negative feedback loop in the regulation of VEGF-induced angiogenesis. Modulation of local PTP1B and/or calpain activities may prove beneficial in the treatment of impaired wound healing in diabetes.

  7. The results demonstrate that the Vegf-Dll4 (show DLL4 Antibodies)/Notch (show NOTCH1 Antibodies) feedback system normally operates to generate heterogeneity between endothelial cells driving blood vessel branching, whilst synchronization drives vessel expansion.

  8. Ginkgo biloba exocarp extract inhibits tumor angiogenesis, which may be closely relevant to its effect in blockage of Wnt /beta-catenin-VEGF signaling pathway in Lewis lung carcinoma.

  9. D2R agonist treatment blocks tumor growth, induces regression of the aberrant blood supply and normalizes blood vessels. An anti-Vegf therapy is also effective to restrain tumor growth and improves vascular remodeling. Importantly, only the combination treatment suppresses intratumoral hemorrhage and restores blood vessel perfusion, suggesting that it might represent an attractive therapy targeting tumor vasculature

  10. VEGF-A mRNA and protein expression were upregulated in choroidal neovascularization; these changes were ameliorated by restoration of miR (show MLXIP Antibodies)-93 by means of transfection.

Pig (Porcine) Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. Here we demonstrate that VEGF-165 mediates MSC (show MSC Antibodies) differentiation into ECs via VEGFR-2 (show KDR Antibodies)-dependent induction of Sox18 (show SOX18 Antibodies), which ultimately coordinates the transcriptional upregulation of specific markers of the EC phenotype.

  2. VEGF was significantly downregulated 7 days after cryotherapy of the sclera and stayed at that level until day 14. It returned to baseline by day 21.

  3. VEGF production, blood vessel network and follicle remodeling are impaired by the antiprogesterone RU486.

  4. findings suggest that the augmented neovascular response seen with VEGF administration was through the VEGF-induced upregulation of Notch (show NOTCH1 Antibodies) signaling.

  5. interleukin-1beta-induced vascular endothelial growth factor in airway smooth muscle cells

  6. Upregulation of VEGF during hypoxia in chondrocyte is mediated partially through HIF-1alpha (show HIF1A Antibodies).

  7. data shows that members of the VEGF-VEGFR (show KDR Antibodies) system are temporally and spatially well localized for playing key roles during umbilical cord formation and its intensive growth observed after day 75 of pregnancy

  8. cardiac-specific and hypoxia-induced coexpression of VEGF and Ang1 (show ANGPT1 Antibodies) improves the perfusion and function of porcine MI heart through the induction of angiogenesis and cardiomyocyte proliferation

  9. The mRNA for VEGFA was expressed in early developing and in maturing glomeruli.

  10. Data show that subventricular zone neural stem cells express VEGF and all VEGF splice variants, VEGFR1 (show FLT1 Antibodies), VEGFR2 (show KDR Antibodies) and Neuropilin-1 (show NRP1 Antibodies) and -2 mRNAs.

Horse (Equine) Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. Peripheral Blood-Derived Mesenchymal Stromal Cells Promote Angiogenesis via Paracrine Stimulation of Vascular Endothelial Growth Factor Secretion

  2. TNF (show TNF Antibodies) may up-regulate VEGF and stimulate angiogenesis in the mare (show C16orf35 Antibodies) early corpus luteum.

Guinea Pig Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. After acoustic trauma, vascular endothelial growth factor was up-regulated both in the cochlea and vestibule. Expression in both structures suggests a reparative role with potentially therapeutic implications.

  2. Studied the role of T help 17 cells (Th17) and STAT3-VEGF pathway in pathogenesis of psoriasis.

Rabbit Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. VEGF mRNA abundance was present at low levels at 16 h post-ovulation and remained low at 72 h, but the level increased at 144 h in uterus.

  2. correlation was observed between CT perfusion parameters (BF, BV, PS, and MAV (show KLHL2 Antibodies)) and expression of VEGF and MVD (show MVD Antibodies) in tumor tissue

  3. Physiologic ischemic training stimulates VEGF-mediated mobilization of endothelial progenitor cells as well as angiogenesis.

  4. Suggest supplemental oxygen inhibits HIF-1alpha/VEGF signaling to reduce smooth muscle proliferation in rabbit arteriovenous fistula model.

  5. Therefore, it was reasonable to speculate that the increased expression of VEGF and MMP-9 (show MMP9 Antibodies) in residual hepatic tumor cells and tumor angiogenesis post-embolization would be responsible for the increased metastatic potentiality and invasiveness.

  6. VEGF expression peaked at 8 weeks after meniscus transplantation

  7. Studied the biocompatibility and neovascularization of the PLGA nanospheres wrapped with vascular endothelial growth factor (VEGF).

  8. VEGF induces TGF-beta1 (show TGFB1 Antibodies) expression and myofibroblast transformation after glaucoma surgery.

  9. The results of this study are promising concerning the role of VEGF as a diagnostic marker in moderate osteoarthritis

  10. The overexpression of VEGF increased tumor growth and vascularization, favored cyst formation, and reduced tumor necrosis.

Rhesus Monkey Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. VEGF plays an important role in choroid-retinal endothelial cell proliferation and tube formation.

  2. These findings suggest that FBLN5 (show FBLN5 Antibodies) may interfere with choroidal neovascularization by downregulating VEGF, CXCR4 (show CXCR4 Antibodies), and TGFB1 (show TGFB1 Antibodies) expression and inhibiting choroidl endothelial cell proliferation.

  3. Apelin may play a role in the development of central retinal vein occlusion (CRVO). Apelin has a unique upstream signaling pathway, independent of the VEGF pathway.

  4. Dll4 play an important role in choroidal neovascularization (CNV) angiogenesis, which appears to be regulated by HIF-1alpha and VEGF during the progression of CNV under hypoxic conditions.

  5. A functional network involving VEGF, IGF2, and MMP9 (show MMP9 Antibodies) in early placental trophoblast cells and maternal endometrium appears to be important for normal placentation.

VEGF (VEGFA) Antigen Profile

Antigen Summary

This gene is a member of the PDGF/VEGF growth factor family and encodes a protein that is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Elevated levels of this protein is linked to POEMS syndrome, also known as Crow-Fukase syndrome. Mutations in this gene have been associated with proliferative and nonproliferative diabetic retinopathy. Alternatively spliced transcript variants, encoding either freely secreted or cell-associated isoforms, have been characterized. There is also evidence for the use of non-AUG (CUG) translation initiation sites upstream of, and in-frame with the first AUG, leading to additional isoforms.

Alternative names and synonyms associated with VEGF (VEGFA)

  • vascular endothelial growth factor Aa (vegfaa) antibody
  • vascular endothelial growth factor A (vegfa-a) antibody
  • vascular endothelial growth factor A (VEGFA) antibody
  • vascular endothelial growth factor A (vegfa) antibody
  • vascular endothelial growth factor A (Vegfa) antibody
  • eVEGF120 antibody
  • eVEGF164 antibody
  • MVCD1 antibody
  • vefg antibody
  • Vegf antibody
  • VEGF-A antibody
  • Vegf120 antibody
  • VEGF164 antibody
  • Vegf188 antibody
  • vegfa antibody
  • Vpf antibody
  • wu:fj82c06 antibody

Protein level used designations for VEGFA

VEGF-A-A , etID309976.16 , vascular endothelial growth factor A , vascular endothelial growth factor A-A , vegf-a , vascular endothelial growth factor A-a , vascular endothelial growth factor 164 , vascular permeability factor , VEGF-A , VPF , vascular endothelial growth factor 188 , angiogenic factor , Vascular permeability factor , endothelial growth factor-164 , vascular endothelial growth factor VEGF

GENE ID SPECIES
30682 Danio rerio
373589 Xenopus laevis
493845 Felis catus
100038089 Xenopus (Silurana) tropicalis
281572 Bos taurus
7422 Homo sapiens
22339 Mus musculus
83785 Rattus norvegicus
397157 Sus scrofa
403802 Canis lupus familiaris
395909 Gallus gallus
100033839 Equus caballus
443103 Ovis aries
100713483 Cavia porcellus
100860957 Capra hircus
100008899 Oryctolagus cuniculus
101839822 Mesocricetus auratus
574209 Macaca mulatta
Selected quality suppliers for anti-VEGF (VEGFA) Antibodies
Did you look for something else?